Trial · NCT03386721
Adverse events4,620
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 4,620
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort A (QW/Q2W) | 3 | 26 | 3 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort B (QW/Q2W) | 11 | 32 | 18 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 1 (QW/Q2W) | 0 | 3 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 2 (Q3W) | 1 | 5 | 3 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 3 (Q3W) | 0 | 2 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part I Cohort F (Q3W) | 5 | 22 | 7 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part II Cohort E, Arm 1 (QW/Q2W) | 0 | 3 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | NSCLC: Part II Cohort E, Arm 2 (Q3W) | 0 | 2 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | SCCHN: Part III Cohort G (Q3W) | 15 | 23 | 29 |
| other | ANAEMIA | Blood and lymphatic system disorders | SCCHN: Part III Cohort H (Q3W) | 9 | 30 | 13 |
| other | ANAEMIA | Blood and lymphatic system disorders | ESCC: Part III Cohort I (Q3W) | 7 | 33 | 8 |
| other | ANAEMIA | Blood and lymphatic system disorders | CSCC: Part III Cohort J (Q3W) | 23 | 47 | 40 |
| other | ANAEMIA | Blood and lymphatic system disorders | SCCHN: Part III Cohort K (QW/Q2W) | 11 | 25 | 29 |
| other | ANAEMIA | Blood and lymphatic system disorders | ESCC: Part III Cohort M (QW/Q2W) | 0 | 2 | 0 |
| other | ANAEMIA | Blood and lymphatic system disorders | CSCC: Part III Cohort N (QW/Q2W) | 0 | 1 | 0 |
| other | COAGULOPATHY | Blood and lymphatic system disorders | NSCLC: Part I Cohort A (QW/Q2W) | 0 | 26 | 0 |
| other | COAGULOPATHY | Blood and lymphatic system disorders | NSCLC: Part I Cohort B (QW/Q2W) | 0 | 32 | 0 |
| other | COAGULOPATHY | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 1 (QW/Q2W) | 0 | 3 | 0 |
| other | COAGULOPATHY | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 2 (Q3W) | 0 | 5 | 0 |
| other | COAGULOPATHY | Blood and lymphatic system disorders | NSCLC: Part I Cohort D, Arm 3 (Q3W) | 0 | 2 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03386721/events